Colonial Trust Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Buy
2,602
+202
+8% +$18K 0.02% 188
2026
Q1
$172K Buy
2,400
+1,912
+392% +$147K 0.01% 211
2025
Q4
$38.7K Sell
488
-85
-15% -$6.7K ﹤0.01% 375
2025
Q3
$43.2K Buy
573
+324
+130% +$22.2K ﹤0.01% 360
2025
Q2
$17.2K Sell
249
-51
-17% -$3.34K ﹤0.01% 459
2025
Q1
$20.3K Sell
300
-28
-9% -$1.68K ﹤0.01% 430
2024
Q4
$14.7K Sell
328
-511
-61% -$28.7K ﹤0.01% 443
2024
Q3
$52.7K Sell
839
-33
-4% -$1.93K ﹤0.01% 329
2024
Q2
$51.5K Sell
872
-477
-35% -$29.8K ﹤0.01% 319
2024
Q1
$108K Sell
1,349
-95
-7% -$7.26K 0.01% 238
2023
Q4
$114K Sell
1,444
-140
-9% -$9.96K 0.01% 223
2023
Q3
$111K Sell
1,584
-29
-2% -$2.06K 0.01% 234
2023
Q2
$112K Sell
1,613
-97
-6% -$6.9K 0.01% 238
2023
Q1
$127K Sell
1,710
-255
-13% -$21.4K 0.01% 226
2022
Q4
$183K Hold
1,965
0.02% 203
2022
Q3
$187K Buy
+1,965
New +$195K 0.03% 194
2018
Q1
Sell
-3,520
Closed -$255K 152
2017
Q4
$255K Buy
+3,520
New +$256K 0.04% 150

Other funds holding CVS

Colonial Trust Advisors's CVS Position: Q2 2026 in Review

Colonial Trust Advisors increased its CVS Health (CVS) stake by 8.4% in Q2 2026, buying an estimated $18K and bringing the position to 2,602 shares worth $269K. The position accounts for 0.02% of the portfolio, ranked #188.

Colonial Trust Advisors first reported a position in CVS in Q4 2017 and has held it in 17 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Colonial Trust Advisors held 2,602 shares of CVS Health worth $269K as of Q2 2026.
  • Colonial Trust Advisors bought 202 CVS Health shares in Q2 2026, an estimated $18K.
  • CVS Health made up 0.02% of Colonial Trust Advisors's portfolio in Q2 2026, its #188 holding.
  • Colonial Trust Advisors first reported a position in CVS Health in Q4 2017 and has held it in 17 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.